Proposed Data Collection Submitted for Public Comment and Recommendations, 60609-60610 [2017-27481]
Download as PDF
<![CDATA[
60609
Federal Register / Vol. 82, No. 244 / Thursday, December 21, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
ABCs Invasive Pneumococcal Disease in Children Case Report
Form.
ABCs Surveillance for Non-Invasive Pneumococcal Pneumonia
(SNiPP) Case Report Form.
ABCs H.influenzae Neonatal Sepsis Expanded Surveillance Form ....
ABCs Severe GAS Infection Supplemental Form—NEW FORM ........
ABCs Neonatal Infection Expanded Tracking Form .............................
FoodNet Campylobacter .......................................................................
FoodNet Cryptosporidium .....................................................................
FoodNet Cyclospora .............................................................................
FoodNet Listeria monocytogenes .........................................................
FoodNet Salmonella .............................................................................
FoodNet Shiga toxin producing E. coli .................................................
FoodNet Shigella ..................................................................................
FoodNet Vibrio ......................................................................................
FoodNet Yersinia ..................................................................................
FoodNet Hemolytic Uremic Syndrome .................................................
Influenza Hospitalization Surveillance Network Case Report Form .....
Influenza Hospitalization Surveillance Project Vaccination Phone
Script Consent Form (English).
Influenza Hospitalization Surveillance Project Vaccination Phone
Script Consent Form (Spanish).
Influenza Hospitalization Surveillance Project Provider Vaccination
History Fax Form (Children/Adults).
HAIC CDI Case Report Form ...............................................................
HAIC Multi-site Gram-Negative Bacilli Case Report Form (MuGSI–
CRE/CRAB).
HAIC Multi-site Gram-Negative Bacilli Case Report Form for
Carbapenem-resistant Pseudomonas aeruginosa(CR–PA)—NEW
FORM.
HAIC Multi-site Gram-Negative Surveillance Initiative—ExtendedSpectrum Beta-Lactamase-Producing Enterobacteriaceae (MuGSI–
ESBL)—NEW FORM.
HAIC Invasive Methicillin-resistant Staphylococcus aureus (MRSA) ...
HAIC Invasive Methicillin-sensitive Staphylococcus aureus (MSSA)—
NEW FORM.
HAIC Candidemia Case Report Form—NEW FORM ..........................
Total ........................................
...............................................................................................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–27482 Filed 12–20–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–18–18EV; Docket No. CDC–2017–
0105]
daltland on DSKBBV9HB2PROD with NOTICES
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
SUMMARY:
VerDate Sep<11>2014
20:57 Dec 20, 2017
Jkt 244001
Frm 00032
Fmt 4703
Sfmt 4703
Average
burden per
response
(in hours)
Total
burden
(in hours)
10
22
10/60
37
10
125
10/60
208
10
10
10
10
10
10
10
10
10
10
10
10
10
10
10
6
136
37
850
130
3
13
827
190
290
25
30
10
1,000
333
10/60
20/60
20/60
21/60
10/60
10/60
20/60
21/60
20/60
10/60
10/60
10/60
1
25/60
5/60
10
453
123
2,975
217
5
43
2,895
633
483
42
50
100
4,167
278
10
333
5/60
278
10
333
5/60
278
10
10
1,650
500
30/60
20/60
8,250
1,667
10
344
45/60
2,580
10
1,200
20/60
4,000
10
10
609
1,035
20/60
20/60
2,030
3,450
9
800
20/60
2,400
....................
....................
....................
40,347
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Enhanced Surveillance for
Histoplasmosis. CDC will collect state
health department and patient furnished
histoplasmosis case data.
DATES: CDC must receive written
comments on or before February 20,
2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0105 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
PO 00000
Number of
responses
per
respondent
Number of
respondents
Form name
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all Federal
comments through the Federal
eRulemaking portal (regulations.gov) or
by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
E:\FR\FM\21DEN1.SGM
21DEN1
60610
Federal Register / Vol. 82, No. 244 / Thursday, December 21, 2017 / Notices
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Enhanced Surveillance for
Histoplasmosis—New—National Center
for Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Histoplasmosis is an infectious
disease caused by inhalation of the
environmental fungus Histoplasma
capsulatum. Histoplasmosis can range
from asymptomatic or mild illness to
severe disseminated disease, and it is
often described as the most common
endemic mycosis in North America.
However, much still remains unknown
about the epidemiology and patient
burden of histoplasmosis in the United
States. Histoplasmosis is currently
reportable in 11 states but is not
nationally notifiable. In June 2016, the
Council of State and Territorial
Epidemiologists (CSTE) passed a
position statement to standardize the
case definition for histoplasmosis, a first
step towards more consistent
surveillance methodology. A recent
multistate analysis of histoplasmosis
cases reported to public health during
2011–2014 also revealed variation in the
data elements collected by each state,
limiting inter-state comparability. In
addition, data on possible exposures,
underlying medical conditions,
symptoms, and antifungal treatment was
only collected in a few states.
Furthermore, no multistate data exists
about histoplasmosis cases identified
using the newly-created CSTE case
definition.
More detailed data about
histoplasmosis cases detected during
routine surveillance are needed to better
understand the features of persons at
risk, characterize the effects of
histoplasmosis on patients (e.g., delays
in diagnosis, symptom duration, and
decreased productivity), understand
patient awareness of histoplasmosis,
and determine its true public health
burden. This information will not only
help inform routine surveillance
practices, but also guide awareness
efforts and appropriate prevention
strategies.
For a period of one year, health
department personnel in participating
states will conduct telephone interviews
with reported histoplasmosis cases that
meet the CSTE case definition and will
record responses on a standardized
form. The form will collect information
on demographics, underlying medical
conditions, exposures, symptom type
and duration, healthcare-seeking
behaviors, diagnosis, treatment, and
outcomes.
This interview activity is consistent
with the state’s existing authority to
investigate reports of notifiable diseases
for routine surveillance purposes;
therefore, formal consent to participate
in the surveillance is not required.
However, cases may choose not to
participate and may choose not to
answer any question they do not wish
to answer.
It will take health department
personnel approximately 15 minutes to
administer the questionnaire to 300
patient respondents and 15 minutes for
health department personnel to retrieve
and record diagnostic information from
their state reportable disease database.
This results in an estimated annual
burden to the public of 150 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses
per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total
burden
(in hours)
Type of respondents
Form name
Histoplasmosis cases ...........................
Health department personnel ...............
Case Report Form for Histoplasmosis Enhanced Surveillance ....
Case Report Form for Histoplasmosis Enhanced Surveillance ....
300
10
1
30
15/60
15/60
75
75
Total ..............................................
.........................................................................................................
....................
....................
....................
150
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
daltland on DSKBBV9HB2PROD with NOTICES
BILLING CODE 4163–18–P
VerDate Sep<11>2014
20:57 Dec 20, 2017
Jkt 244001
Correction to Notice Published
12/13/2017
Robert Sargis,
Reports Clearance Officer.
Title: Adoption and Foster Care
Analysis Reporting System for title IV–
B and title
IV–E (AFCARS).
OMB No.: 0970–0422.
Description: The notice, vol. 82, page
58615, published 12/13/2017 was an
[FR Doc. 2017–27481 Filed 12–20–17; 8:45 am]
Administration for Children and
Families
erroneous re-publication of a notice
published on 10/20/2017 at vol. 82,
page 48821. No additional comments
are being solicited at this time. We
regret the confusion it may have caused.
[FR Doc. 2017–27479 Filed 12–20–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Frm 00033
Fmt 4703
Sfmt 9990
BILLING CODE 4184–01–P
E:\FR\FM\21DEN1.SGM
21DEN1
]]>Agencies
[Federal Register Volume 82, Number 244 (Thursday, December 21, 2017)]
[Notices]
[Pages 60609-60610]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-27481]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-18-18EV; Docket No. CDC-2017-0105]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Enhanced Surveillance for
Histoplasmosis. CDC will collect state health department and patient
furnished histoplasmosis case data.
DATES: CDC must receive written comments on or before February 20,
2018.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0105 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all Federal comments through the Federal
eRulemaking portal (regulations.gov) or by U.S. mail to the address
listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Leroy A. Richardson, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
[[Page 60610]]
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Enhanced Surveillance for Histoplasmosis--New--National Center for
Emerging and Zoonotic Infectious Diseases, Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Histoplasmosis is an infectious disease caused by inhalation of the
environmental fungus Histoplasma capsulatum. Histoplasmosis can range
from asymptomatic or mild illness to severe disseminated disease, and
it is often described as the most common endemic mycosis in North
America. However, much still remains unknown about the epidemiology and
patient burden of histoplasmosis in the United States. Histoplasmosis
is currently reportable in 11 states but is not nationally notifiable.
In June 2016, the Council of State and Territorial Epidemiologists
(CSTE) passed a position statement to standardize the case definition
for histoplasmosis, a first step towards more consistent surveillance
methodology. A recent multistate analysis of histoplasmosis cases
reported to public health during 2011-2014 also revealed variation in
the data elements collected by each state, limiting inter-state
comparability. In addition, data on possible exposures, underlying
medical conditions, symptoms, and antifungal treatment was only
collected in a few states. Furthermore, no multistate data exists about
histoplasmosis cases identified using the newly-created CSTE case
definition.
More detailed data about histoplasmosis cases detected during
routine surveillance are needed to better understand the features of
persons at risk, characterize the effects of histoplasmosis on patients
(e.g., delays in diagnosis, symptom duration, and decreased
productivity), understand patient awareness of histoplasmosis, and
determine its true public health burden. This information will not only
help inform routine surveillance practices, but also guide awareness
efforts and appropriate prevention strategies.
For a period of one year, health department personnel in
participating states will conduct telephone interviews with reported
histoplasmosis cases that meet the CSTE case definition and will record
responses on a standardized form. The form will collect information on
demographics, underlying medical conditions, exposures, symptom type
and duration, healthcare-seeking behaviors, diagnosis, treatment, and
outcomes.
This interview activity is consistent with the state's existing
authority to investigate reports of notifiable diseases for routine
surveillance purposes; therefore, formal consent to participate in the
surveillance is not required. However, cases may choose not to
participate and may choose not to answer any question they do not wish
to answer.
It will take health department personnel approximately 15 minutes
to administer the questionnaire to 300 patient respondents and 15
minutes for health department personnel to retrieve and record
diagnostic information from their state reportable disease database.
This results in an estimated annual burden to the public of 150 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average
Number of responses burden per Total
Type of respondents Form name respondents per response burden (in
respondent (in hours) hours)
----------------------------------------------------------------------------------------------------------------
Histoplasmosis cases................ Case Report Form for 300 1 15/60 75
Histoplasmosis
Enhanced Surveillance.
Health department personnel......... Case Report Form for 10 30 15/60 75
Histoplasmosis
Enhanced Surveillance.
---------------------------------------------------
Total........................... ...................... ........... ........... ........... 150
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-27481 Filed 12-20-17; 8:45 am]
BILLING CODE 4163-18-P
